Pediatric Neurology
Volume 29, Issue 3 , Pages 253-255 , September 2003

Localized morphea: a rare adverse effect of valproic acid

  • George T Ferzli, MD

      Affiliations

    • Department of Pediatrics, American University of Beirut Medical Center, New York, New York, USA
  • ,
  • Abd-el-Kader El-Tal, MD

      Affiliations

    • Department of Dermatology, American University of Beirut Medical Center, New York, New York, USA.
  • ,
  • Abdul-Ghani Kibbi, MD, FACP

      Affiliations

    • Department of Dermatology, American University of Beirut Medical Center, New York, New York, USA.
  • ,
  • Mohamad A Mikati, MD

      Affiliations

    • Department of Pediatrics, American University of Beirut Medical Center, New York, New York, USA
    • Corresponding Author InformationCommunications should be addressed to: Dr. Mikati; Department of Pediatrics; American University of Beirut; 3 Dag Hammarskjold Plaza; 8th floor; New York, NY 10017-2303, USA.

Received 5 December 2002 ,Accepted 17 March 2003.

References 

  1. Rosenwasser TA, Eisen AZ. Scleroderma. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine, Vol. 2, 4th ed. New York: McGraw-Hill Inc., 1993:2156-67
  2. Schmidt D. Sodium valproate. In: Seldon L, Schmidt D, eds. Adverse effects of antiepileptic drugs. New York: Raven Press, 1982:145-8
  3. Goihman-Yahr M, Leal G, Essenfeld-Yahr E. Generalizedmorphea (A side effect of valproate sodium?). Arch Dermatol. 1980;116:621
  4. Polderman MC, Pavel S, Vermeer BJ, Wintzen M. Ultraviolet A-I phototherapy for skin diseases. Ned Tijdschr Geneeskd. 1999;143:931–934
  5. Sapadin AN, Fleischmajer R. Treatment of scleroderma. Arch Dermatol. 2002;138:99–105
  6. Hurwitz S. Unclassified disorders. In: Hurwitz S, ed. Clinical pediatric dermatology, 2nd ed. Philadelphia: WB Saunders, 1993:663-93

PII: S0887-8994(03)00214-5

doi: 10.1016/S0887-8994(03)00214-5

Pediatric Neurology
Volume 29, Issue 3 , Pages 253-255 , September 2003